Cannabis is well established as a medicine and should not prevent patients from receiving a necessary transplant
A new wave of research points toward cannabinoids having an adaptive, immunomodulating effect.
Very high doses of CBD might interact with immunosuppressive drug used in transplant patients
Project CBD speaks with neuroscientist Greg Gerdeman on the endocannabinoid system and the biology of wellness
Antibiotic-resistant infections are a growing health crisis. CBD-rich cannabis could be a potent tool in the fight against them.
A new study from scientists at the University of South Carolina described how CB1 inhibition by Rimonabant leads to changes in gene regulation.
An “orphan receptor” is the term for a receptor in the body whose natural activator is not known.
Indian researchers suggest that overactivity of ABHD6 limits the body's ability to quell its overactive response to interferons.
Sex research has often been misused to stigmatize marginalized groups.
Preventive medicine is a hot topic these days as everyone is looking for ways to stay healthy and avoid illness.
Science abstracts on CBD and Immune Function
- CBD inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpes virus-infected endothelium
- Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study.
- Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation.
- High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana.
- Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.
- Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation.
- A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)
- The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.
- VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways.
- Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis.
- Cannabis sativa as a Potential Treatment for Systemic Sclerosis.
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.
- Medical cannabis: Another piece in the mosaic of autoimmunity?
- The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders.
- Targeting the Cannabinoid Pathway Limits the Development of Fibrosis and Autoimmunity in a Mouse Model of Systemic Sclerosis
- Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1.
- Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts.
- EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis.
These links are from third-party sites and are provided as a courtesy to the reader.
THE ESSENTIAL GUIDE TO CBD
By the Editors of Reader’s Digest & Project CBD: Everything You Need to Know About What It Helps, Where to Buy It, and How to Take It.